Tag: University of Miami
Yes, Nick Buoniconti was a famous football player. He was a member of the Miami Dolphins’ “Perfect Season” and Super Bowl championship teams. He was known for playing middle linebacker with a passion, tracking down quarterbacks like a heat-seeking missile.
He was an integral part of the Dolphins’ glory years.
But as Buoniconti’s legacy is reassessed following his death on Tuesday, it’s pretty much unanimous that it’s what he did after he left the field — and a horrific family tragedy — that truly meant the most to so many South Floridians.
What if paralyzed limbs could move using only the power of one’s thoughts? Borrowing a story line from the realm of science fiction, a team of researchers at The Miami Project to Cure Paralysis—together with neurosurgeons and biomedical engineers from the University of Miami Miller School of Medicine—are using a brain-machine interface to make this once seemingly impossible feat a reality for victims of spinal cord injury (SCI). Seeking innovative ways to restore function after SCI is one of the central goals for The Miami Project, which was founded in 1985 and has grown to become one of the “crown jewels” of the Miller School of Medicine—and a model for other institutions developing centers for SCI research.
A five-year grant from National Institute on Disability, Independent Living, and Rehabilitation Research funds multi-site study of intermittent hypoxia in spinal cord injury
East Hanover, NJ – Kessler Foundation has been awarded an $857,600 sub-award from the Department of Health and Human Services, Administration for Community Living, National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), to study a promising new intervention for upper limb dysfunction after spinal cord injury (SCI).
The Miami Project, at the University of Miami Miller School of Medicine, today announced the publication of its first Food and Drug Administration (FDA) approved Phase I clinical trial involving Schwann cells used to repair the damaged spinal cord, in the February issue of the Journal of Neurotrauma. Schwann cells are essential for the repair of nerve damage, and long thought to be able to increase recovery after spinal cord injury. The trial, performed at University of Miami / Jackson Memorial Hospital in Miami, is the first in a series designed to evaluate the safety and feasibility of transplanting autologous human Schwann cells to treat individuals with spinal cord injuries.
After six months, the patients in the StemCells, Inc. trial being conducted at University of Miami Hospital are demonstrating improvements in both strength and function. They are the first cohort in the Phase II pathway study, led by Allan D. Levi, M.D., Ph.D., professor and Chair of the Department of Neurological Surgery and The Miami Project to Cure Paralysis, which is measuring the effects of implanting stem cells in patients with cervical spinal cord injury (SCI). The assessment of motor function involved using tests of dexterity and grip.
Levi, who is also Chief of Neurosurgery at Jackson Memorial Hospital, was the first investigator to perform a stem cell transplant into the chronically injured cervical spinal cord of a patient.